TriTAC® Technology
Watch our TriTAC technology unleash the target cell-killing properties of a patient’s own immune system.
Science
Harpoon has created a novel antibody-based drug discovery platform called TriTAC®, which offers a new way to unleash the target cell-killing properties of a patient’s own immune system.
Careers
Harpoon is seeking energetic, passionate scientists and innovators to join our effort.
Recent News
September 28,
2023
Harpoon Therapeutics Presents HPN217 Interim Phase 1 Data at the IMS Annual Meeting
September 15,
2023
Harpoon Therapeutics Announces First Patients with Small Cell Lung Cancer Dosed in HPN328 Combination Cohort